AI assistant
Sending…
BICYCLE THERAPEUTICS PLC — Director's Dealing 2020
Jan 6, 2020
32777_dirs_2020-01-06_27e29f79-0153-4f20-a4f6-75602285b9d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2020-01-02
Reporting Person: Skynner Michael (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-02 | Employee Stock Option (right to buy) | $9.82 | A | 60000 | Acquired | 2030-01-02 | Ordinary Shares (60000) | Direct |
Footnotes
F1: This option shall vest one-fourth (1/4) of the total number of shares under option on January 2, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month therafter.
More from BICYCLE THERAPEUTICS PLC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 17
Regulatory Filings
2026
Mar 17
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Feb 3